EAGLE PHARMACEUTICALS INC shareholders Q3 2023

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 109 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.93 and the average weighting 0.0%.

EAGLE PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Man Group plc 36,604$577,2450.00%
VICTORY CAPITAL MANAGEMENT INC 28,881$455,4530.00%
Ameritas Investment Partners, Inc. 867$13,6730.00%
Covestor Ltd 85$10.00%
AMERIPRISE FINANCIAL INC 257,480$4,060,4600.00%
STRS OHIO 9,200$1450.00%
STATE OF WISCONSIN INVESTMENT BOARD 12,800$201,8560.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 11,586$182,7110.00%
Nuveen Asset Management, LLC 142,702$2,250,4110.00%
GOLDMAN SACHS GROUP INC 161,253$2,542,9600.00%
BARRETT & COMPANY, INC. 100$1,5770.00%
BLAIR WILLIAM & CO/IL 22,450$354,0370.00%
Citadel Advisors 292,160$4,607,3630.00%
TWO SIGMA ADVISERS, LP 22,517$355,0930.00%
TWO SIGMA INVESTMENTS, LP 32,680$515,3640.00%
Qube Research & Technologies Ltd 17,784$280,4540.00%
Gladius Capital Management LP 1,421$22,4100.00%
PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 42,039$2210.00%
DIMENSIONAL FUND ADVISORS LP 280,688$4,426,2540.00%
AMERICAN INTERNATIONAL GROUP, INC. 5,164$81,4360.00%
External links

This page lists EAGLE PHARMACEUTICALS INC's shareholders in Q3 2023. To view EAGLE PHARMACEUTICALS INC's shareholder history, click here.